I'm pretty confident the proteinuria endpoint will be achieved (given the results released), however still unsure about the eGFR slope reduction endpoint.
From my reading it seems that this figure is much harder to move than proteinuria unless I'm mistaken?
Ann: Dimerix to present at Melbourne Twilight Investor Briefing, page-60
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $214.4M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.0¢ | $481.7K | 1.265M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 142483 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 105 | 2 |
View Market Depth
| Last trade - 15.38pm 27/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |